PRME · Company research
Prime Medicine, Inc. Common Stock (PRME): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 3.9 | $509,521,564.5 | 462070564.500 | — | — | — | 441.5264857019064125 | 12.7991550779974378 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.